Transgene Biotek Ltd

BSE
TRABI •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Transgene Biotek Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
178.45% Gain from 52W Low
26.8
TTM PE Ratio
Negative PE TTM
-115.2
Price to Book Ratio
Below industry Median
7.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.3
RSI
RSI Overbought
73.8
MFI
MFI strongly Overbought
81.7

Transgene Biotek Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Transgene Biotek Ltd shareholding Pattern

Promoter
23.6%
Public
76.4%
Promoter
23.6%
Public
76.4%
Promoter
23.6%
Public
76.4%
Promoter
23.6%
Public
76.4%
Promoter
23.6%
Public
76.4%
Promoter
23.6%
Public
76.4%

Transgene Biotek Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
10.00
10Day EMA
9.70
12Day EMA
9.60
20Day EMA
9.20
26Day EMA
8.90
50Day EMA
8.40
100Day EMA
8.20
200Day EMA
7.70
5Day SMA
10.10
10Day SMA
9.50
20Day SMA
9.20
30Day SMA
8.60
50Day SMA
7.70
100Day SMA
8.20
150Day SMA
8.90
200Day SMA
8.10
Delivery & Volume
Resistance & Support
10.19
Pivot
Resistance
First Resistance
10.37
Second Resistance
10.67
Third Resistance
10.85
Support
First Support
9.89
Second support
9.71
Third Support
9.41
Relative Strength Index
73.79
Money Flow Index
81.70
MACD
0.64
MACD Signal
0.57
Average True Range
0.53
Average Directional Index
50.45
Rate of Change (21)
12.25
Rate of Change (125)
13.39
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
GKB Ophthalmics Ltd.
-
-
-
One Global Service Provider Ltd.
-
-
-
Family Care Hospitals Ltd.
-
-
-
Transgene Biotek Ltd.
-
-
-
Maestros Electronics & Telecommunications Systems Ltd.
-
-
-
Jeevan Scientific Technology Ltd.
-
-
-
Deccan Health Care Ltd.
-
-
-

Transgene Biotek Ltd Company background

Founded in: 1990
Managing director: K Koteswara Rao
Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India. Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc. The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune.Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immunodiagnostic reagents for qualitative and quantitative estimation of biochemical parameters and diagnosis of diseases respectively.Transgene Bioteks products are exported to Africa, Russia, China, Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility costing Rs. 30 crore at the Anrich Industrial Area, Bollaram. TBL is working of four new plants comprising of Oral deliver of proteins and peptides DNA vaccines fusion proteins and bio therapeutics. The new project is funded through preferential offer to Batterymarch Financial Management USA and Other Financial Institutions (FIs).The Company absorbed the transfer of technology from RBB Inc, USA for the manufacture and marketing of Erythropoietin during year 2003. The Scheme of Arrangement for Amalgamation of M/S Saket Biotechnologies Private Limited (SBPL) with the Company was implemented and made effective on 7th February, 2005. In terms of the said Scheme of Amalgamation, 60,60,000 Equity Shares were allotted to the Sharesholders of M/S Saket Biotechnologies Private limited on 27 April 2005.In 201213, the Company started the commercial production of Omega3 DHA (Docosahexaenoic Acid) . It formulated the molecule belonging to a very large global pharma company for undergoing studies at its own chosen facilities in USA during year 202021. Transgene has been developing novel oral and nasal formulations for the delivery of various protein and peptidebased biologicals through oral and intranasal routes. Transgene is focused on developing novel therapies in the areas of Oncology, AutoImmune diseases and new drug delivery technologies, that have the potential to substantially improve the quality of life of patients in areas of unmet medical need.
Read More

Transgene Biotek Ltd FAQs

You can easily buy Transgene Biotek Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -